slides · global inventory
List
Component collection for the active corpus filters, with each row opening the slide detail view.
Matching slides 110,471
Current window 78,601-78,630
Pages 3,683
Rows per page 30
Component
78,601-78,630 of 110,471
43
The slide uses a metaphorical 'new letter in your alphabet' to describe the expansion of the genetic code.Absci | IPO Presentation Deck | 65 slides · Absci
Pitch deck Investment bank 1 hit
52
The slide uses a linear process flow to map financial milestones to development stages.Absci | IPO Presentation Deck | 65 slides · Absci
Pitch deck Investment bank 1 hit
03
Alkermes | Results Presentation Deck | 13 slidesAlkermes | Results Presentation Deck | 13 slides · Alkermes
Conference presentation Investor relations Beat · What Is1 hit
07
The chart uses a vertical bar format to visualize quarterly trends in TRx MOT.Alkermes | Results Presentation Deck | 13 slides · Alkermes
Conference presentation Investor relations Beat · KPI OverviewLoop · Voice Of Customer1 hit
09
Product introduction slide for Alkermes.Alkermes | Results Presentation Deck | 13 slides · Alkermes
Conference presentation Investor relations Beat · KPI OverviewLoop · Voice Of Customer1 hit
08
Allego | SPAC Presentation Deck | 37 slidesAllego | SPAC Presentation Deck | 37 slides · Allego
Pitch deck Investment bank Beat · SolutionLoop · Quick Win Big Bet1 hit
10
Includes a map visualization of charging sites and a list of key performance metrics.Allego | SPAC Presentation Deck | 37 slides · Allego
Pitch deck Investment bank Beat · SolutionLoop · Quick Win Big Bet1 hit
19
Uses a classic TAM/SAM/SOM style visualization with an additional outer layer for total fleet size.Allego | SPAC Presentation Deck | 37 slides · Allego
Pitch deck Investment bank 1 hit
22
The chart uses a waterfall-like progression to show growth in charging ports.Allego | SPAC Presentation Deck | 37 slides · Allego
Pitch deck Investment bank Loop · Cost Of Inaction1 hit
23
The slide uses a combination of a three-column service breakdown and a comparison table for client case studies.Allego | SPAC Presentation Deck | 37 slides · Allego
Pitch deck Investment bank Loop · Cost Of Inaction1 hit
26
The slide uses a timeline diagram to illustrate historical project wins and their scope.Allego | SPAC Presentation Deck | 37 slides · Allego
Pitch deck Investment bank Loop · Cost Of Inaction1 hit
32
Includes detailed footnotes regarding transaction assumptions and currency conversion.Allego | SPAC Presentation Deck | 37 slides · Allego
Pitch deck Investment bank 1 hit
08
The bar chart shows growth from Q2 2020 to Q2 2021. The pie chart shows the composition of sales by North America, International, and AWS.Amazon | Results Presentation Deck | 19 slides · Amazon
Conference presentation Investor relations Beat · KPI OverviewLoop · Logic Chain1 hit
04
argenx SE | Investor Day Presentation Deck | 69 slidesargenx SE | Investor Day Presentation Deck | 69 slides · argenx
Conference presentation Investor relations Beat · Situation & Context1 hit
14
The slide uses a Venn-like diagram to connect core company values to specific market and pipeline achievements.argenx SE | Investor Day Presentation Deck | 69 slides · argenx
Conference presentation Investor relations 1 hit
15
The slide uses a Venn-like diagram to connect three core pillars to six specific business achievements.argenx SE | Investor Day Presentation Deck | 69 slides · argenx
Conference presentation Investor relations 1 hit
17
The slide uses a numbered list to explain a biological process (pinocytosis, binding, rescue, release) mapped to a visual diagram.argenx SE | Investor Day Presentation Deck | 69 slides · argenx
Conference presentation Investor relations 1 hit
21
Data from Phase 3 ADAPT trial; includes comparison to Phase 2 pemphigus trial findings.argenx SE | Investor Day Presentation Deck | 69 slides · argenx
Conference presentation Investor relations 1 hit
26
The slide uses a circular process flow to explain the pathology of Immune-Mediated Necrotizing Myopathy (IMNM).argenx SE | Investor Day Presentation Deck | 69 slides · argenx
Conference presentation Investor relations Beat · Problem & ComplicationLoop · Cost Of Inaction1 hit
27
The slide uses a process-flow framework to show how autoantibodies trigger specific biological pathways (myolysis, capillary disruption, interferon production) leading to muscle atrophy.argenx SE | Investor Day Presentation Deck | 69 slides · argenx
Conference presentation Investor relations Beat · Problem & ComplicationLoop · Cost Of Inaction1 hit
28
The diagram illustrates a hub-and-spoke model where the autoantibody is the central mediator.argenx SE | Investor Day Presentation Deck | 69 slides · argenx
Conference presentation Investor relations Beat · Problem & ComplicationLoop · Cost Of Inaction1 hit
30
argenx SE | Investor Day Presentation Deck | 69 slidesargenx SE | Investor Day Presentation Deck | 69 slides · argenx
Conference presentation Investor relations Beat · Evidence & ProofLoop · Aha Moment1 hit
31
The slide shows 8 individual patient longitudinal plots. Each plot has dual y-axes (CK and Anti-SRP54) and a shared x-axis (Days).argenx SE | Investor Day Presentation Deck | 69 slides · argenx
Conference presentation Investor relations Beat · Evidence & ProofLoop · Aha Moment1 hit
32
The chart is a Kaplan-Meier survival curve showing 'DOI-free Survival Probability' over time in weeks.argenx SE | Investor Day Presentation Deck | 69 slides · argenx
Conference presentation Investor relations Beat · Evidence & ProofLoop · Aha Moment1 hit
35
The chart uses a diagonal line to represent growth or accumulation of patient segments.argenx SE | Investor Day Presentation Deck | 69 slides · argenx
Conference presentation Investor relations Beat · Evidence & ProofLoop · Aha Moment1 hit
40
The slide depicts a step-by-step biological pathway (1-6) showing how autoantibodies lead to blister formation. It also highlights the therapeutic target Efgartigimod.argenx SE | Investor Day Presentation Deck | 69 slides · argenx
Conference presentation Investor relations Beat · Evidence & ProofLoop · Aha Moment1 hit
54
The slide uses a process flow diagram to justify targeting C2. It contrasts this with other potential targets (labeled 1 and 2) and highlights the benefits of C2 inhibition.argenx SE | Investor Day Presentation Deck | 69 slides · argenx
Conference presentation Investor relations Beat · Impact & Next Steps1 hit
56
The slide uses a timeline-like structure to show dose escalation cohorts for IV and SC administration.argenx SE | Investor Day Presentation Deck | 69 slides · argenx
Conference presentation Investor relations Beat · Impact & Next Steps1 hit
57
The slide presents clinical trial safety data for ARGX-117, highlighting that most adverse events are low grade and unrelated to the drug.argenx SE | Investor Day Presentation Deck | 69 slides · argenx
Conference presentation Investor relations Beat · Impact & Next Steps1 hit
58
SAD = Single Ascending Dose. PD = Pharmacodynamic.argenx SE | Investor Day Presentation Deck | 69 slides · argenx
Conference presentation Investor relations Beat · Impact & Next Steps1 hit